Cyclin-dependent kinase 4/6 activity is a critical determinant of pre-replication complex assembly
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/onc2008319.pdf
Reference58 articles.
1. Aggarwal P, Lessie MD, Lin DI, Pontano L, Gladden AB, Nuskey B et al. (2007). Nuclear accumulation of cyclin D1 during S phase inhibits Cu14-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication. Genes Dev 21: 2908–2922.
2. Angus SP, Mayhew CN, Solomon DA, Braden WA, Markey MP, Okuno Y et al. (2004). RB reversibly inhibits DNA replication via two temporally distinct mechanisms. Mol Cell Biol 24: 5404–5420.
3. Bartek J, Bartkova J, Lukas J . (1997). The retinoblastoma protein pathway in cell cycle control and cancer. Exp Cell Res 237: 1–6.
4. Bartkova J, Lukas J, Bartek J . (1997). Aberrations of the G1- and G1/S-regulating genes in human cancer. Prog Cell Cycle Res 3: 211–220.
5. Bell SP, Dutta A . (2002). DNA replication in eukaryotic cells. Annu Rev Biochem 71: 333–374.
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A systematic review on understanding the mechanistic pathways and clinical aspects of natural CDK inhibitors on cancer progression.: Unlocking cellular and biochemical mechanisms;Chemico-Biological Interactions;2024-04
2. Retraction Note: Cyclin-dependent kinase 4/6 activity is a critical determinant of pre-replication complex assembly;Oncogene;2023-03-22
3. Benvitimod inhibits MCM6-meditated proliferation of keratinocytes by regulating the JAK/STAT3 pathway;Journal of Dermatological Science;2023-02
4. RB1 loss triggers dependence on ESRRG in retinoblastoma;Science Advances;2022-08-19
5. Precision Medicine Highlights Dysregulation of the CDK4/6 Cell Cycle Regulatory Pathway in Pediatric, Adolescents and Young Adult Sarcomas;Cancers;2022-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3